(Q51724587)

10 April 2018

title

Impaired stem cell function of CD34+ cells selected by two different immunomagnetic beads systems. (English)

1 reference

10 April 2018

author name string

Kimura T

1

1 reference

10 April 2018

Minamiguchi H

2

1 reference

10 April 2018

Wang J

3

1 reference

10 April 2018

Kaneko H

4

1 reference

10 April 2018

Nakagawa H

5

1 reference

10 April 2018

Fujii H

6

1 reference

10 April 2018

Sonoda Y

7

1 reference

10 April 2018

publication date

1 March 2004

1 reference

10 April 2018

published in

Leukemia

1 reference

10 April 2018

volume

18

1 reference

10 April 2018

issue

3

1 reference

10 April 2018

page(s)

566-574

1 reference

10 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403211

exact match

0 references

cites work

Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

CD34+ cell engraftment, ex vivo expansion, and malignant cell depletion following immunomagnetic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

Human cord blood-derived primitive progenitors are enriched in CD34+c-kit- cells: correlation between long-term culture-initiating cells and telomerase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

A newly discovered class of human hematopoietic cells with SCID-repopulating activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

7 January 2021

A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

7 January 2021

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

7 January 2021

CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

7 January 2021

Immune reconstitution after autologous selected peripheral blood progenitor cell transplantation: comparison of two CD34+ cell-selection systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

7 January 2021

Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

7 January 2021

SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

7 January 2021

Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

7 January 2021

Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

7 January 2021

Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403211

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403211

1 reference

10 April 2018

release_whrdggvrhnctpa25eh3mpmo4hm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/whrdggvrhnctpa25eh3mpmo4hm

24 November 2022

mapped directly with Wikidata item

1 reference

10 April 2018